Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2014 / Cilt: 25 - Sayı: 2

Obesity and irritable bowel syndrome

Obezite ve irritabl bağırsak sendromu

Pages
127–132
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since İBS is frequently experienced by family physicians in primary care, it is important to make studies on İBS and risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Obesity is one of the most common health problems in developed and developing countries.
📊
Key Findings & Data:Between February 1 and March 1 2013, 124 obese patients were included in the study.
💡
Conclusion & Impact:Since İBS is frequently experienced by family physicians in primary care, it is important to make studies on İBS and risk factors.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: Obesity is one of the most common health problems in developed and developing countries. On the other hand, İBS is one of the quite common diseases that impair quality of life, leading to a functional bowel disorder. The aim of this study was to find the frequency of İBS in obese patients and risk factors associated with İBS. Methods: A cross-sectional study was carried out in obese patients who attended the outpatient clinic of obesity. Between February 1 and March 1 2013, 124 obese patients were included in the study. İBS was diagnosed based on Rome III diagnostic criteria. Organic pathologies that affect bowel movements were excluded. Patients who had systemic diseases (diabetes, chronic renal failure, systemic lupus erythematosus, multiple sclerosis, thyroid dysfunction) and patients on drugs (antihypertensive calcium channel blockers and beta-blockers) affecting bowel movements were not included in this study. Patientsdemographic and clinical informations were recorded. Results: 79.8% of the patients were female, mean age 39.1±10.5 years. According to Rome III criteria 10.5% of patients met the diagnosis criteria of İBS. We found statistically significant correlation between smoking and frequency of İBS (p=0.003). On the other hand we didn t find statistically significant correlation between gender, age, education level and İBS. Conclusion: In our obese study group, the prevalence of İBS is not different than in the general population. Similar to results of other studies, smoking was found to be a risk factor for IBS. Since İBS is frequently experienced by family physicians in primary care, it is important to make studies on İBS and risk factors.

Özet

Amaç: Obezite günümüzde gelişmiş ve gelişmekte olan ülkelerin en önemli sağlık sorunları arasında yer almaktadır. İrritabl bağırsak sendromu (İBS) da toplumda oldukça sık rastlanan, yaşam kalitesini bozan fonksiyonel bir bağırsak hastalığıdır. Çalışmamızın amacı obez hastalarda İBS sıklığını araştırmak ve İBS sıklığı ile ilişkili faktörleri incelemektir. Gereç ve Yöntem: Bu çalışmaya 1 Şubat - 1 Mart 2013 tarihleri arasında hastanemiz obezite ünitesine başvuran 124 hasta dahil edilmiştir. İBS tanısı, mevcut organik patolojiler dışlanarak, Roma III tanı kriterlerine göre konulmuştur. Çalışmaya alarm semptomları olan, bağırsak hareketlerini etkileyen sistemik hastalıkları olan (diyabet, kronik böbrek yetmezliği, sistemik lupus eritematosus, multiple skleroz, tiroid fonksiyon bozukluğu v.b.), bağırsak hareketlerini etkileyebilecek ilaç (antihipertansif olarak kalsiyum kanal blokeri, beta bloker ve antidepresanlar v.b.) kullanımı olan hastalar dahil edilmemiştir. Bulgular: Hastaların % 79,8 i kadın, ortalama yaşı 39,1±10,5 yıl olarak tespit edilmiştir. Hastaların %10,5inde Roma III tanı kriterlerine göre İBS saptanmıştır. Obez hastalarda sigara kullanımı ile İBS sıklığı arasında istatiksel olarak anlamlı ilişki saptanmıştır (p=0.003). Buna karşılık cinsiyet, yaş, vücut kitle indeksi, eğitim durumu ve ek hastalık varlığı ile İBS arasında istatiksel anlamlı ilişki saptanmamıştır. Sonuç: Çalışmamızda obez hastalardaki İBS sıklığı toplumdaki İBS sıklığıyla benzer bulunmuştur. Obez hastalarda sigara kullanımının İBS sıklığını arttıran önemli faktör olarak tespit edilmiştir. Birinci basamak sağlık hizmetlerinde İBS, aile hekimleri tarafından sıklıkla karşılaşılan bir sorun olması nedeniyle ilgili durumların ve risk faktörlerinin belirlenmesi için daha geniş çaplı kontrollü çalışmalara ihtiyaç vardır. Anahtar sözcükler:

🔖

Cite This Article

EĞİCİ, M. T., AHISHALI, E., TEMİZKAN, Ş., DABAK, R., KARABAYRAKTAR, T., TEKİN, B., DOLAPÇIOĞLU, C. (2022). Obesity and irritable bowel syndrome. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 25 - Sayı: 2, 127–132. https://ajindex.com/articles/571351

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002
  2. 122(6):1701-14. 2.Talley NJ, Spiller R. Irrıtable bowel syndrome: a little understood organic bowel disease? Lancet 2002
  3. Camilleri M, Ford MJ. Colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment Pharmocol Ther 1998
  4. Locke GR, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000
  5. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987
  6. Switz DM. What the gastroenterologist does all day: a survey of a state society’s practice. Gastroenterology 1976
  7. Russo MW, Gaynes BN, Drossman DA. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 1999
  8. 339–343. 8.Çelebi S, Açık Y, Deveci SE, Bahcecioglu IH, Ayar A, Demir A, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004
  9. Karaman N, Türkay C, Yönem Ö. Irritable bowel syndrome prevalence in city center of Sivas. Turk J Gastroenterol 2003
  10. Şimşek İ, Şengül B. İrritabl barsak sendromu. Aktüel Tıp Dergisi 2004
  11. Yılmaz Ş, Dursun M, Ertem M, Canoruc F, Turhanoğlu A. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study. Int J Clin Pract 2005
  12. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978
  13. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006
  14. Willett WC, Dietz WH, Colditz GA Guidelines for healthy weight. N Engl J Med 1999
  15. Van Oijen MG, Josemanders DF, Laheij RJ, van Rossum LG, Tan AC, Jansen JB. Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med 2006
  16. Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agréus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 2005
  17. Ho W, Spiegel BM, The Relationship Between Obesity and Functional Gastrointestinal Disorders: Causation, Association, or Neither? Ga